SN
Santen Pharmaceutical Co., Ltd.
SNPHF · OTC
$10.99 -15.79% (-$2.06)
Market Cap ¥555.1B
P/E Ratio 14.29x
Div. Yield 2.25%
ROE 17.61%
Bulios Fair Price
$13.14
19.6% upside
Trenutna cena
$10.99
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica SNPHF trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
8/9Valuation
89 /100
Cheap EV/EBITDA 7.78x
P/S 1.90x
P/B 1.86x
Growth
62 /100
Stable Rev. growth 4.06%
FCF growth 74.56%
Book val. growth 5.34%
Profitability
78 /100
Strong Net margin 13.26%
Op. margin 15.69%
FCF margin 12.04%
Quality
70 /100
Excellent ROE 17.61%
ROA 9.41%
Asset turnover 0.71x
Debt
100 /100
Low Current ratio 2.82x
Int. coverage 23.50x
Net debt/EBITDA -0.72x
Stability
38 /100
Moderate Rev. volatility 4.47%
EPS volatility 222.54%
Profitable years 2
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SNPHF
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Takeshi Ito
Employees
3,968
Headquarters
Kita
Prihajajoči dogodki
29 SEP.
Ex-Dividend
Ex-dividend date
29 SEP.
Dividend Payment
Datum plačila
05 NOV.
Earnings
Upcoming earnings report
30 MAR.
Ex-Dividend
Ex-dividend date
30 MAR.
Dividend Payment
Datum plačila